BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Treatment
21 results:

  • 1. Chimeric antigen receptor T-cell therapy-induced nervous system toxicity: a real-world study based on the FDA Adverse Event Reporting System database.
    Ren X; Zhang G; Li G; Wang Y
    BMC Cancer; 2024 Jan; 24(1):10. PubMed ID: 38166723
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
    Kuan AS; Chiang CL; Wu HM; Yang HC; Chen CJ; Lin CJ; Guo WY; Pan DH; Chung WY; Lee CC
    J Neurooncol; 2023 Sep; 164(3):729-739. PubMed ID: 37721662
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
    Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
    J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients.
    Friedrich MJ; Neri P; Kehl N; Michel J; Steiger S; Kilian M; Leblay N; Maity R; Sankowski R; Lee H; Barakat E; Ahn S; Weinhold N; Rippe K; Bunse L; Platten M; Goldschmidt H; Müller-Tidow C; Raab MS; Bahlis NJ
    Cancer Cell; 2023 Apr; 41(4):711-725.e6. PubMed ID: 36898378
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive bcma Expression Profiling in Adult Normal Human brain Suggests a Low Risk of On-target Neurotoxicity in bcma-targeting Multiple Myeloma Therapy.
    Marella M; Yao X; Carreira V; Bustamante MF; Clark HB; Jackson CC; Zudaire E; Schecter JM; Glover TD; Shenton J; Cornax I
    J Histochem Cytochem; 2022 Apr; 70(4):273-287. PubMed ID: 35193424
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study.
    Guven DC; Acar R; Yekeduz E; Bilgetekin I; Baytemur NK; Erol C; Ceylan F; Sendur MA; Demirci U; Urun Y; Karadurmus N; Erman M; Kilickap S
    Curr Probl Cancer; 2021 Dec; 45(6):100760. PubMed ID: 34130864
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Application of Chimeric Antigen Receptor T Cells in the treatment of Hematological Malignancies.
    Yan W; Liu Z; Liu J; Xia Y; Hu K; Yu J
    Biomed Res Int; 2020; 2020():4241864. PubMed ID: 33062678
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical features and diagnosis of secondary adrenal insufficiency followed complex treatment nonpituitary brain tumors].
    Yudina AE; Pavlova MG; Sotnikov VM; Yudina AE; Sych YP; Mazerkina NA; Zheludkova OG; Teryaeva NB; Gerasimov AN; Martynova E; Kim EI; Berkovskaya MA
    Probl Endokrinol (Mosk); 2019 Nov; 65(5):330-340. PubMed ID: 32202737
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
    Ryu JY; Min KL; Chang MJ
    PLoS One; 2019; 14(12):e0225599. PubMed ID: 31790459
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI).
    Yomo S; Serizawa T; Yamamoto M; Higuchi Y; Sato Y; Shuto T; Akabane A; Jokura H; Kawagishi J; Aoyama H
    J Neurooncol; 2019 Oct; 145(1):151-157. PubMed ID: 31487030
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Adaptive Hermite Fractal Tree (AHFT): a novel surgical 3D path planning approach with curvature and heading constraints.
    Pinzi M; Galvan S; Rodriguez Y Baena F
    Int J Comput Assist Radiol Surg; 2019 Apr; 14(4):659-670. PubMed ID: 30790172
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Complications after stereotactic radiosurgery for brain metastases: Incidences, correlating factors, treatments and outcomes.
    Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H; Barfod BE
    Radiother Oncol; 2018 Nov; 129(2):364-369. PubMed ID: 30293644
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Membrane proteome analysis of glioblastoma cell invasion.
    Mallawaaratchy DM; Buckland ME; McDonald KL; Li CC; Ly L; Sykes EK; Christopherson RI; Kaufman KL
    J Neuropathol Exp Neurol; 2015 May; 74(5):425-41. PubMed ID: 25853691
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain.
    Avraham HK; Jiang S; Fu Y; Nakshatri H; Ovadia H; Avraham S
    J Pathol; 2014 Feb; 232(3):369-81. PubMed ID: 24421076
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Bilateral metastases of renal cell carcinoma to the ovaries--a case report].
    Hołody-Zareba J; Kinalski P; Sulkowski S; Kozłowski R; Kinalski M
    Ginekol Pol; 2013 Jul; 84(7):650-3. PubMed ID: 24032280
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Barfod BE; Kasuya H; Urakawa Y
    J Neurosurg; 2013 Jun; 118(6):1258-68. PubMed ID: 23600938
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis.
    Appelman-Dijkstra NM; Kokshoorn NE; Dekkers OM; Neelis KJ; Biermasz NR; Romijn JA; Smit JW; Pereira AM
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2330-40. PubMed ID: 21613351
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.
    Awasthi R; Rathore RK; Soni P; Sahoo P; Awasthi A; Husain N; Behari S; Singh RK; Pandey CM; Gupta RK
    Neuroradiology; 2012 Mar; 54(3):205-13. PubMed ID: 21541688
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cost-effectiveness analysis of trastuzumab (herceptin) in HER2-overexpressed metastatic breast cancer.
    Perez-Ellis C; Goncalves A; Jacquemier J; Marty M; Girre V; Roché H; Brain E; Moatti JP; Viens P; Le Corroller-Soriano AG
    Am J Clin Oncol; 2009 Oct; 32(5):492-8. PubMed ID: 19487912
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk for hospitalization with depression after a cancer diagnosis: a nationwide, population-based study of cancer patients in Denmark from 1973 to 2003.
    Dalton SO; Laursen TM; Ross L; Mortensen PB; Johansen C
    J Clin Oncol; 2009 Mar; 27(9):1440-5. PubMed ID: 19224839
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.